- Two Investigational Meds Promising for Myasthenia Gravis Medscape
- UCB presents efficacy and safety results for zilucoplan and rozanolixizumab in generalized myasthenia gravis UCB
- View Full Coverage on Google News
Serwis informacyjny, platforma współpracy grupowej, szkolenia i egzaminy